Kangzhe Pharmaceutical Holdings Limited has secured the Overseas Issuance and Listing Registration Notice from the International Cooperation Department of the China Securities Regulatory Commission (CSRC), paving the way for its introduction listing on the Singapore Exchange. Notably, this listing will not entail the issuance of new shares.